Rapid Mood Screener (RMS)

The Rapid Mood Screener (RMS) is a pragmatic six-item, yes or no questionnaire that helps clinicians identify patients whose depressive symptoms may reflect bipolar I disorder rather than major depressive disorder. Developed by McIntyre and colleagues in 2021, it screens adults already reporting depression and flags when a fuller bipolar assessment is warranted.

Why healthcare providers use the RMS

Reduces misdiagnosis. Many people with bipolar I disorder first present with depression, and the RMS helps separate them from major depressive disorder before treatment planning.
Fast to complete. Six yes or no questions take about a minute, making the tool practical for busy primary care and psychiatric visits.
Evidence-based cutoff. A validated threshold gives providers a consistent signal for when to pursue a more thorough assessment.
Patient-friendly. Plain-language questions let patients self-report without specialist training or lengthy interviews.

Which settings use the RMS?

Primary care. Clinicians use it to catch bipolar features in patients who present with depressive symptoms.
Psychiatry and behavioral health. Providers use it during intake to guide differential assessment before diagnosis.
Integrated care and telehealth. Teams administer it remotely to triage patients before an appointment.

What does the RMS measure?

The RMS asks about a patient's history of manic and hypomanic experiences alongside features that research links more strongly to bipolar I disorder than to unipolar depression. It does not measure current depression severity; instead it captures markers that help distinguish the two conditions.

Manic and hypomanic symptoms. Items probe past periods of elevated mood, increased energy, and reduced need for sleep.
Course of illness. Questions ask about early onset of depression and the number of prior depressive episodes.
Associated features. Items cover characteristics that research associates with bipolar I, such as behavioral and psychomotor changes.

Scoring the RMS

Number of items: 6.
Per-item scale: each item is scored yes (1) or no (0).
Total score range: 0 to 6.
Score direction: higher scores indicate a greater likelihood of bipolar I disorder.

A positive screen is not a diagnosis. The RMS flags patients who warrant a comprehensive clinical evaluation, and results should be interpreted alongside history, presentation, and clinical judgment. Because the tool was validated in adults already reporting depressive symptoms, it is not intended as a general population screen. The developers established a single cutoff rather than graded severity bands, so a score of four or more endorsed items is the recognized threshold for a positive screen.

Score	Interpretation	Suggested next step
0 to 3	Negative screen for bipolar I disorder	Continue routine assessment and monitor
4 to 6	Positive screen, consistent with possible bipolar I disorder	Consider further comprehensive evaluation

Best practices for administration

Screen the right patients. Use the RMS with adults who are already reporting depressive symptoms, the population it was validated in.
Explain the purpose. Tell patients the questions ask about mood across their lifetime, not just the recent few weeks.
Ask about lifetime history. Several items refer to past episodes, so encourage patients to consider their whole history.
Pair with clinical judgment. Treat the score as one input that prompts follow-up, not a standalone decision.
Rescreen when the picture changes. Repeat screening if new symptoms or history emerge that could shift the differential.

How Zentake helps with the RMS

Automatic scoring. Totals are calculated on submit, with no hand-tallying.
Before the visit. Patients complete it from home on any device, and mental health practices start informed because the clinician has the results ready before the appointment.
HIPAA compliant. Responses are encrypted, with a signed BAA on every plan.

References

McIntyre RS, Patel MD, Masand PS, et al. The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder. Current Medical Research and Opinion. 2021;37(1):135-144. This validation study established the six-item structure and the four-item cutoff, reporting a sensitivity of 0.88 and a specificity of 0.80 for distinguishing bipolar I disorder from major depressive disorder in adults with depressive symptoms.

Last updated: August 2026

Rapid Mood Screener questions, answered.

What is the RMS used for?

The Rapid Mood Screener is used to help clinicians tell whether an adult's depressive symptoms may reflect bipolar I disorder rather than major depressive disorder. It is a screening aid that flags patients who need a fuller diagnostic evaluation, not a tool that confirms or rules out any diagnosis on its own.

How many questions are on the RMS?

The RMS has six questions, each answered yes or no. Three questions focus on symptoms of mania and hypomania, while the others ask about features such as early onset and multiple depressive episodes that research links more closely to bipolar I disorder than to unipolar depression. It takes about a minute to complete.

How is the RMS scored?

Each of the six items scores one point for a yes answer and zero for a no, giving a total from zero to six. Higher totals suggest a greater likelihood of bipolar I disorder. A total of four or more endorsed items is considered a positive screen that warrants further clinical evaluation.

What does a positive RMS result mean?

A positive screen, meaning four or more yes answers, indicates the patient's presentation is consistent with possible bipolar I disorder and should prompt a comprehensive diagnostic assessment. It does not confirm bipolar disorder by itself. Clinicians interpret the result alongside the patient's history, current symptoms, and overall clinical judgment before drawing conclusions.

Who should be screened with the RMS?

The RMS was validated in adults who are already reporting depressive symptoms, so it is best used with patients presenting with depression rather than as a general population screen. Primary care, psychiatry, and behavioral health teams use it to decide whether a fuller bipolar I evaluation is warranted for a given patient.

Is the RMS a diagnostic test?

No. The RMS is a screening tool, not a diagnostic test. It identifies patients whose depressive symptoms may reflect bipolar I disorder and signals when further assessment is needed. A diagnosis requires a comprehensive clinical evaluation by a qualified professional, using established criteria, history, and examination rather than a screening score alone.